Advances in Clinical Chemistry
- 1st Edition, Volume 102 - May 26, 2021
- Latest edition
- Editor: Gregory S. Makowski
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 2 4 6 1 4 - 6
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 5 0 9 9 - 5
Advances in Clinical Chemistry, Volume 102, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scient… Read more
Advances in Clinical Chemistry, Volume 102, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the most up-to-date technologies related to the field of clinical chemistry. Chapters in this new release cover Advances in immunosensor technology, Extracellular Vesicles: Roles and Applications in Drug-Induced Liver Injury, Oxidative stress biomarkers in the preterm infant, Translational biomarkers in the era of precision medicine, Metabolomics applications in coronary artery disease personalized medicine, Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers.
- Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
- Authored by world-renowned clinical laboratory scientists, physicians and research scientists
- Presents the international benchmark for novel analytical approaches in the clinical laboratory
Clinical Laboratory Professionals, Physicians and Research Scientists
1. Advances in immunosensor technology
Muhammet Aydin, Elif Burcu Aydin and Mustafa Kemal Sezgintürk
2. Extracellular Vesicles: Roles and Applications in Drug-Induced Liver Injury
David S. Umbaugh and Hartmut Jaeschke
3. Oxidative stress biomarkers in the preterm infant
Angel Sanchez-Illana, Jose David Pineiro-Ramos, Victoria Ramos-Garcia, Isabel Ten-Domenech, Maximo Vento and Julia Kuligowski
4. Translational biomarkers in the era of precision medicine
Laura Bravo-Merodio, Animesh Acharjee, Dominic Russ, Vartika Bisht, John A. Williams, Loukia G. Tsaprouni and Georgios V. Gkoutos
5. Metabolomics applications in coronary artery disease personalized medicine
Arwa M. Amin
6. Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers
Yvonne Holler and Raffaele Nardone
- Edition: 1
- Latest edition
- Volume: 102
- Published: May 26, 2021
- Language: English
GM
Gregory S. Makowski
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.
Affiliations and expertise
Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USARead Advances in Clinical Chemistry on ScienceDirect